vs
Hims & Hers Health, Inc.（HIMS）与湘南美容医疗集团（SBC）财务数据对比。点击上方公司名可切换其他公司
Hims & Hers Health, Inc.的季度营收约是湘南美容医疗集团的15.6倍（$617.8M vs $39.6M）。湘南美容医疗集团净利率更高（35.9% vs 3.3%，领先32.6%）。Hims & Hers Health, Inc.同比增速更快（28.4% vs -10.9%）。湘南美容医疗集团自由现金流更多（$51.2M vs $-2.5M）。过去两年Hims & Hers Health, Inc.的营收复合增速更高（49.0% vs -15.0%）
Hims & Hers Health, Inc.是2017年成立的美国远程医疗企业，面向消费者提供处方药品、非处方药物以及各类个人护理产品，依托线上服务模式为用户打造便捷的健康消费渠道，覆盖日常医疗、个护等多场景需求。
湘南美容医疗集团是总部位于日本的知名医疗服务提供商，核心业务覆盖美容整形、皮肤科诊疗、抗衰老健康护理等领域，在日本各地运营大量连锁诊所，同时服务本地居民及赴日就医的国际游客。
HIMS vs SBC — 直观对比
营收规模更大
HIMS
是对方的15.6倍
$39.6M
营收增速更快
HIMS
高出39.3%
-10.9%
净利率更高
SBC
高出32.6%
3.3%
自由现金流更多
SBC
多$53.7M
$-2.5M
两年增速更快
HIMS
近两年复合增速
-15.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $617.8M | $39.6M |
| 净利润 | $20.6M | $14.2M |
| 毛利率 | 71.9% | 73.1% |
| 营业利润率 | 1.5% | 32.5% |
| 净利率 | 3.3% | 35.9% |
| 营收同比 | 28.4% | -10.9% |
| 净利润同比 | -20.8% | 117.2% |
| 每股收益（稀释后） | $0.08 | $0.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HIMSSBC
| Q4 25 | $617.8M | $39.6M | ||
| Q3 25 | $599.0M | $43.4M | ||
| Q2 25 | $544.8M | $43.4M | ||
| Q1 25 | $586.0M | $47.3M | ||
| Q4 24 | $481.1M | $44.4M | ||
| Q3 24 | $401.6M | $53.1M | ||
| Q2 24 | $315.6M | $53.1M | ||
| Q1 24 | $278.2M | $54.8M |
净利润HIMSSBC
| Q4 25 | $20.6M | $14.2M | ||
| Q3 25 | $15.8M | $12.8M | ||
| Q2 25 | $42.5M | $2.5M | ||
| Q1 25 | $49.5M | $21.5M | ||
| Q4 24 | $26.0M | $6.5M | ||
| Q3 24 | $75.6M | $2.8M | ||
| Q2 24 | $13.3M | $18.5M | ||
| Q1 24 | $11.1M | $18.8M |
毛利率HIMSSBC
| Q4 25 | 71.9% | 73.1% | ||
| Q3 25 | 73.8% | 70.6% | ||
| Q2 25 | 76.4% | 69.2% | ||
| Q1 25 | 73.5% | 79.7% | ||
| Q4 24 | 76.8% | 76.3% | ||
| Q3 24 | 79.2% | 81.5% | ||
| Q2 24 | 81.3% | 74.2% | ||
| Q1 24 | 82.4% | 72.1% |
营业利润率HIMSSBC
| Q4 25 | 1.5% | 32.5% | ||
| Q3 25 | 2.0% | 36.6% | ||
| Q2 25 | 4.9% | 33.6% | ||
| Q1 25 | 9.9% | 51.1% | ||
| Q4 24 | 3.9% | 10.6% | ||
| Q3 24 | 5.6% | 26.1% | ||
| Q2 24 | 3.5% | 51.4% | ||
| Q1 24 | 3.6% | 44.6% |
净利率HIMSSBC
| Q4 25 | 3.3% | 35.9% | ||
| Q3 25 | 2.6% | 29.6% | ||
| Q2 25 | 7.8% | 5.7% | ||
| Q1 25 | 8.4% | 45.4% | ||
| Q4 24 | 5.4% | 14.7% | ||
| Q3 24 | 18.8% | 5.3% | ||
| Q2 24 | 4.2% | 34.8% | ||
| Q1 24 | 4.0% | 34.2% |
每股收益（稀释后）HIMSSBC
| Q4 25 | $0.08 | $0.15 | ||
| Q3 25 | $0.06 | $0.12 | ||
| Q2 25 | $0.17 | $0.02 | ||
| Q1 25 | $0.20 | $0.21 | ||
| Q4 24 | $0.10 | $0.05 | ||
| Q3 24 | $0.32 | $0.03 | ||
| Q2 24 | $0.06 | $0.20 | ||
| Q1 24 | $0.05 | $0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $228.6M | $164.1M |
| 总债务越低越好 | — | $42.8M |
| 股东权益账面价值 | $540.9M | $248.3M |
| 总资产 | $2.2B | $380.4M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资HIMSSBC
| Q4 25 | $228.6M | $164.1M | ||
| Q3 25 | $345.8M | $127.4M | ||
| Q2 25 | $1.1B | $152.7M | ||
| Q1 25 | $273.7M | $132.1M | ||
| Q4 24 | $220.6M | $125.0M | ||
| Q3 24 | $165.5M | $137.4M | ||
| Q2 24 | $129.3M | — | ||
| Q1 24 | $105.2M | — |
总债务HIMSSBC
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | — | $823.2K | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益HIMSSBC
| Q4 25 | $540.9M | $248.3M | ||
| Q3 25 | $581.0M | $248.0M | ||
| Q2 25 | $562.7M | $244.6M | ||
| Q1 25 | $549.3M | $226.4M | ||
| Q4 24 | $476.7M | $195.1M | ||
| Q3 24 | $440.1M | $205.0M | ||
| Q2 24 | $362.0M | $8.8M | ||
| Q1 24 | $344.5M | $9.0M |
总资产HIMSSBC
| Q4 25 | $2.2B | $380.4M | ||
| Q3 25 | $2.2B | $321.4M | ||
| Q2 25 | $1.9B | $315.3M | ||
| Q1 25 | $891.7M | $284.6M | ||
| Q4 24 | $707.5M | $266.1M | ||
| Q3 24 | $602.3M | $296.5M | ||
| Q2 24 | $480.5M | $19.5M | ||
| Q1 24 | $448.1M | $19.8M |
负债/权益比HIMSSBC
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $61.3M | $52.0M |
| 自由现金流经营现金流 - 资本支出 | $-2.5M | $51.2M |
| 自由现金流率自由现金流/营收 | -0.4% | 129.3% |
| 资本支出强度资本支出/营收 | 10.3% | 2.0% |
| 现金转化率经营现金流/净利润 | 2.98× | 3.66× |
| 过去12个月自由现金流最近4个季度 | $57.4M | $23.3M |
8季度趋势，按日历期对齐
经营现金流HIMSSBC
| Q4 25 | $61.3M | $52.0M | ||
| Q3 25 | $148.7M | $-20.9M | ||
| Q2 25 | $-19.1M | $-8.3M | ||
| Q1 25 | $109.1M | $1.9M | ||
| Q4 24 | $86.4M | $-7.3M | ||
| Q3 24 | $85.3M | $5.0M | ||
| Q2 24 | $53.6M | $19.2M | ||
| Q1 24 | $25.8M | $3.7M |
自由现金流HIMSSBC
| Q4 25 | $-2.5M | $51.2M | ||
| Q3 25 | $79.3M | $-20.9M | ||
| Q2 25 | $-69.5M | $-8.6M | ||
| Q1 25 | $50.1M | $1.7M | ||
| Q4 24 | $59.5M | $-7.9M | ||
| Q3 24 | $79.4M | $4.6M | ||
| Q2 24 | $47.6M | $18.3M | ||
| Q1 24 | $11.8M | $3.0M |
自由现金流率HIMSSBC
| Q4 25 | -0.4% | 129.3% | ||
| Q3 25 | 13.2% | -48.3% | ||
| Q2 25 | -12.8% | -19.9% | ||
| Q1 25 | 8.5% | 3.5% | ||
| Q4 24 | 12.4% | -17.8% | ||
| Q3 24 | 19.8% | 8.7% | ||
| Q2 24 | 15.1% | 34.5% | ||
| Q1 24 | 4.3% | 5.4% |
资本支出强度HIMSSBC
| Q4 25 | 10.3% | 2.0% | ||
| Q3 25 | 11.6% | 0.1% | ||
| Q2 25 | 9.3% | 0.7% | ||
| Q1 25 | 10.1% | 0.5% | ||
| Q4 24 | 5.6% | 1.3% | ||
| Q3 24 | 1.5% | 0.8% | ||
| Q2 24 | 1.9% | 1.6% | ||
| Q1 24 | 5.0% | 1.3% |
现金转化率HIMSSBC
| Q4 25 | 2.98× | 3.66× | ||
| Q3 25 | 9.43× | -1.63× | ||
| Q2 25 | -0.45× | -3.39× | ||
| Q1 25 | 2.20× | 0.09× | ||
| Q4 24 | 3.32× | -1.12× | ||
| Q3 24 | 1.13× | 1.77× | ||
| Q2 24 | 4.03× | 1.04× | ||
| Q1 24 | 2.32× | 0.20× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HIMS
暂无分部数据
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
